News & Updates

Obesity exerts no influence on ventilator-associated pneumonia risk

23 Feb 2021

Obesity appears to have no significant association with the incidence of ventilator-associated pneumonia, a study has found.

Obesity exerts no influence on ventilator-associated pneumonia risk

23 Feb 2021

Dexamethasone lowers mortality, ventilation use in ARDS

22 Feb 2021 by

Treatment with intravenous (IV) dexamethasone for 10 days significantly reduces duration of mechanical ventilation at 28 days and 60-day mortality in patients with established moderate-to-severe acute respiratory disease syndrome (ARDS) compared with no dexamethasone, results of the DEXA-ARDS trial have shown.

Dexamethasone lowers mortality, ventilation use in ARDS

22 Feb 2021

Roflumilast does not ease arterial stiffness in COPD patients

20 Feb 2021

Treatment with the phosphodiesterase 4 inhibitor roflumilast does not appear to provide any benefits on arterial stiffness in patients with chronic obstructive pulmonary disease (COPD), suggest the results of a study.

Roflumilast does not ease arterial stiffness in COPD patients

20 Feb 2021

NONSEDA: Some mechanically ventilated ICU patients need not be sedated

19 Feb 2021 by

Among critically ill adults receiving mechanical ventilation in the intensive care unit (ICU), a protocol of no sedation is comparable to light sedation with daily interruption in terms of mortality, as shown in the NONSEDA trial.

NONSEDA: Some mechanically ventilated ICU patients need not be sedated

19 Feb 2021

COVID-19 school closure may have upped myopia prevalence in children

17 Feb 2021 by

School closures during the COVID-19 pandemic may have led to an increase in the prevalence of myopia in children aged 6–8 years, according to a cross-sectional, prospective study from China.

COVID-19 school closure may have upped myopia prevalence in children

17 Feb 2021

Fears amid deaths: No cause for alarm

16 Feb 2021 by

An unsettling report claiming 23 elderly deaths in Norway after receiving COVID-19 vaccine doses made headlines that sow fears among older adults most vulnerable to SARS-CoV-2. The report, downright disturbing as it was, didn’t tell the full story.

Fears amid deaths: No cause for alarm

16 Feb 2021

Original New Drug Application Approvals by US FDA (01 - 15 February 2021)

16 Feb 2021

New drug applications approved by US FDA as of 01-15 February 2021 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (01 - 15 February 2021)

16 Feb 2021

Real-world data back benralizumab in severe eosinophilic asthma

15 Feb 2021 by

Use of the interleukin-5-receptor monoclonal antibody benralizumab in a real-world setting appears to improve outcomes for patients with severe eosinophilic asthma, allowing some to fully come off their maintenance therapy while preserving disease control, as shown in a study.

Real-world data back benralizumab in severe eosinophilic asthma

15 Feb 2021

Early-childhood asthma symptoms up COPD risk in adulthood

14 Feb 2021

The risk of chronic obstructive pulmonary disease (COPD) doubles among people who had asthma-like symptoms during childhood, reports a recent study.

Early-childhood asthma symptoms up COPD risk in adulthood

14 Feb 2021

Limited transfer of COVID-19 antibodies from mothers to infants during pregnancy

13 Feb 2021 by

While pregnant mothers with COVID-19 can mount a robust antibody response against the virus, transfer of antibodies from mothers to child across the placenta is less efficient than expected, according to a study presented during the SMFM 2021 Meeting.

Limited transfer of COVID-19 antibodies from mothers to infants during pregnancy

13 Feb 2021

News & Updates

Filter by Specialty:

Specialty:

Obesity exerts no influence on ventilator-associated pneumonia risk

Obesity exerts no influence on ventilator-associated pneumonia risk

Dexamethasone lowers mortality, ventilation use in ARDS

Dexamethasone lowers mortality, ventilation use in ARDS

Roflumilast does not ease arterial stiffness in COPD patients

Roflumilast does not ease arterial stiffness in COPD patients

NONSEDA: Some mechanically ventilated ICU patients need not be sedated

NONSEDA: Some mechanically ventilated ICU patients need not be sedated

COVID-19 school closure may have upped myopia prevalence in children

COVID-19 school closure may have upped myopia prevalence in children

Fears amid deaths: No cause for alarm

Fears amid deaths: No cause for alarm

Original New Drug Application Approvals by US FDA (01 - 15 February 2021)

Original New Drug Application Approvals by US FDA (01 - 15 February 2021)

Real-world data back benralizumab in severe eosinophilic asthma

Real-world data back benralizumab in severe eosinophilic asthma

Early-childhood asthma symptoms up COPD risk in adulthood

Early-childhood asthma symptoms up COPD risk in adulthood

Limited transfer of COVID-19 antibodies from mothers to infants during pregnancy

Limited transfer of COVID-19 antibodies from mothers to infants during pregnancy